EFFECTS OF 6 WEEKS OF TREATMENT WITH DAPAGLIFLOZIN, A SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR, ON MYOCARDIAL FUNCTION AND METABOLISM IN TYPE 2 DIABETES PATIENTS: A RANDOMIZED PLACEBO-CONTROLLED STUDY
- Resource Type
- Source
- Journal of the American College of Cardiology. 75:1610
- Subject
business.industry Placebo-controlled study Metabolism Type 2 diabetes Pharmacology medicine.disease Myocardial function chemistry.chemical_compound chemistry medicine Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Cardiology and Cardiovascular Medicine business - Language
- ISSN
- 0735-1097